Mallinckrodt to enter Irish examinership after US plan approved
American-Irish pharmaceuticals manufacturer Mallinckrodt will file examinership proceedings in Dublin in the coming days, after the Delaware bankruptcy court approved its Chapter 11 plan to slash about US$1.3 billion in debt.
To read more
Subscribe to Global Restructuring Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Restructuring Review experts.